The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation

Area of Science:

• Cardiovascular Biology
• Iron Metabolism
• Molecular Endocrinology

Background:

• Hepcidin is a peptide hormone crucial for iron homeostasis, primarily produced in the liver.
• Iron dysregulation is implicated in various cardiac conditions, but hepcidin's cardiac role is largely unknown.
• Understanding hepcidin's cardiac function is vital for novel therapeutic strategies in heart disease.

Purpose of the Study:

• To investigate the expression and regulation of hepcidin in the rat heart.
• To compare cardiac hepcidin expression with hepatic hepcidin regulation.
• To explore the potential role of cardiac hepcidin in cardiovascular pathophysiology.

Main Methods:

• Analysis of hepcidin mRNA and protein levels in rat heart tissue.
• In vivo studies using turpentine injection to induce inflammation and hypoxia exposure.
• Immunofluorescence microscopy for cellular localization of hepcidin in the heart.

Main Results:

• Hepcidin is expressed in the rat heart at both mRNA and protein levels.
• Cardiac hepcidin mRNA increased significantly following turpentine injection, similar to the liver.
• Hypoxia strongly upregulated both cardiac hepcidin mRNA and protein, with localization at the myocardial intercalated discs.

Conclusions:

• The heart expresses and regulates the iron hormone hepcidin.
• Hypoxia induces cardiac hepcidin expression, indicating a potential role in cardiac function and disease.
• These findings highlight hepcidin as a potential target for managing heart conditions associated with iron imbalance.